Conavi Medical Corp.
CNVIF
$0.3238
-$0.0031-0.95%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.62% | -98.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.62% | -98.70% | |||
| Cost of Revenue | 101.16% | -111.61% | |||
| Gross Profit | -55.64% | -96.09% | |||
| SG&A Expenses | -12.54% | -8.61% | |||
| Depreciation & Amortization | 4.71% | -4.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.94% | -22.92% | |||
| Operating Income | 11.20% | -105.29% | |||
| Income Before Tax | -18.21% | 40.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.21% | 40.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.21% | 40.00% | |||
| EBIT | 11.20% | -105.29% | |||
| EBITDA | 11.51% | -110.68% | |||
| EPS Basic | 23.58% | 42.86% | |||
| Normalized Basic EPS | 47.31% | 32.27% | |||
| EPS Diluted | 23.58% | 42.86% | |||
| Normalized Diluted EPS | 47.31% | 32.27% | |||
| Average Basic Shares Outstanding | 54.88% | 4.96% | |||
| Average Diluted Shares Outstanding | 54.88% | 4.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||